# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.2...
The new collaboration will leverage the industry-leading strengths from both companies to provide access to advanced genomics t...
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada